MicroRNA155 Expression in Relation to BDCAF Scored Beh çet's Disease in an Egyptian Patients' Sample.
Conclusion: Increased miRNA155 may be used as a biomarker of BD remission and thus in the disease follow up. There could be a prospect of treating the disease via microRNA 155 effect enhancement.
PMID: 30197703 [PubMed]
Source: Open Rheumatology Journal - Category: Rheumatology Tags: Open Rheumatol J Source Type: research
More News: Egypt Health | Rheumatology